T Cell News and Research

Latest T Cell News and Research

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with other collaborating groups, have discovered the first lipid vascular 'ZIP code' in the lungs.

16 Aug 2023

Deep learning framework DeepAIR could improve understanding of adaptive immunity

Researchers presented a deep learning framework, DeepAIR, to accurately predict adaptive immune receptor (AIR)-antigen binding.

15 Aug 2023

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Scientists have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against EBV in mice.

14 Aug 2023

Unveiling hidden threats: clustering loops in CAR-T cells impact cancer therapy

How complementarity-determining region (CDR) loops in the single-chain variable fragment (scFv) influence chimeric antigen receptor (CAR)-T cell behavior.

14 Aug 2023

Study explores the diverse expression patterns of T cell priming markers across cancers

A recent study explored transcriptomics of T-cell priming markers (TPMs) across different cancers.

10 Aug 2023

MaxCyte and Vittoria Biotherapeutics sign strategic platform license to advance next generation cellular therapies

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, and Vittoria Biotherapeutics (Vittoria), a leading edge, gene-edited cell therapeutics company with novel platform technologies poised to develop a pipeline of highly differentiated cellular therapies for both oncology and immunology indications, today announced the signing of a strategic platform license (SPL) of MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to Vittoria Biotherapeutics.

From MaxCyte, Inc. 10 Aug 2023

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.

9 Aug 2023

Neoantigen discovery sheds light on cancer immunogenicity

Researchers reported a proteogenomic approach to investigate fresh solid melanoma tumor material.

4 Aug 2023

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Researchers explore the distinguishing features of MIS-C as compared to other inflammatory-infectious syndromes in children.

4 Aug 2023

Deep learning improves protein design by 10x

The key to understanding proteins -; such as those that govern cancer, COVID-19, and other diseases -; is quite simple. Identify their chemical structure and find which other proteins can bind to them. But there's a catch.

3 Aug 2023

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Decades of research have left knowledge gaps about cells that regulate the immune system: Purdue and NIH.

1 Aug 2023

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Study examined the role of plasma metagenomic next-generation sequencing.

1 Aug 2023

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Study reveals the events accompanying the COVID-19 infection cascade in the nasal mucosa and free circulation

1 Aug 2023

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

27 Jul 2023

Tails on engineered T cells could help fight cancer

Previous
1
...
6
7
8
9
10
11
12
...
2895
Next

T Cell News and Research

Latest T Cell News and Research

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Deep learning framework DeepAIR could improve understanding of adaptive immunity

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Unveiling hidden threats: clustering loops in CAR-T cells impact cancer therapy

Study explores the diverse expression patterns of T cell priming markers across cancers

MaxCyte and Vittoria Biotherapeutics sign strategic platform license to advance next generation cellular therapies

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Neoantigen discovery sheds light on cancer immunogenicity

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Deep learning improves protein design by 10x

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Tails on engineered T cells could help fight cancer

Tumor-derived GDF-15 suppresses immunotherapy response

Targeting chronic endometritis: study reveals potential diagnostic markers

Unlocking the secrets of asymptomatic COVID-19 infections: HLA-B*15:01 connection revealed

Designing vaccines to induce a stronger immune response to infecting pathogens

Using 'click chemistry' to create novel multi-protein anti-cancer agents

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in